Back to Search
Start Over
Avadel Pharmaceuticals Announces Restructuring to Focus on FT218 Clinical Development Program
- Source :
- GlobeNewswire. February 7, 2019
- Publication Year :
- 2019
-
Abstract
- DUBLIN, Ireland, Feb 07, 2019 (GLOBE NEWSWIRE via COMTEX) -- - Company cost structure expected to be reduced by $70 to $75 million in 2019 -- Approximately $100 million in [...]
Details
- Language :
- English
- Database :
- Gale General OneFile
- Journal :
- GlobeNewswire
- Publication Type :
- News
- Accession number :
- edsgcl.572936919